| 2024-01-16 | Sale | Mersana Therapeutics, Inc. MRSN | VP, Chief Accounting Officer | 5,025 0.0042% | $2.71 | $13,618 | +25.09% | |
| 2023-01-17 | Sale | Mersana Therapeutics, Inc. MRSN | VP, Controller | 3,575 0.0033% | $5.74 | $20,521 | -41.65% | |
| 2022-01-18 | Sale | Mersana Therapeutics, Inc. MRSN | VP, Controller | 3,964 0.0052% | $5.92 | $23,467 | -7.05% | |
| 2021-07-01 | Sale | Mersana Therapeutics, Inc. MRSN | VP, Controller | 1,884 0.0026% | $13.60 | $25,622 | -56.37% | |
| 2021-01-19 | Sale | Mersana Therapeutics, Inc. MRSN | VP, Controller | 1,090 0.0008% | $10.64 | $11,598 | -40.52% | |
| 2021-01-04 | Sale | Mersana Therapeutics, Inc. MRSN | VP, Controller | 494 0.0004% | $13.38 | $6,610 | -48.11% | |
| 2020-07-02 | Sale | Mersana Therapeutics, Inc. MRSN | VP, Controller | 6,766 0.0101% | $22.49 | $152,167 | -15.72% | |
| 2020-06-30 | Mersana Therapeutics, Inc. MRSN | VP, Controller | 6,766 0.0058% | $13.68 | $92,559 | -20.36% |